Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pharmaceutical Economics and Policy
TopicLeading institutions, researchers & key papers
This cluster of papers explores the economics of pharmaceutical research and development, focusing on topics such as drug development costs, generic drugs, pharmaceutical innovation, medicine prices, patent expiry, healthcare policies, market size, availability of medicines, and generic substitution.
173
Works
IDs:OpenAlex
How has Pharmaceutical Economics and Policy's publication output changed over time?
ScholarIQpublication output · 2007–2024
Output grew0% over the shown period — from 1 works in 2007 to 1 in 2024.
1
1
1
2
1
1
1
3
1
1
2007200820102014201620172018202020222024
What are the most-cited papers on Pharmaceutical Economics and Policy?
ScholarIQmost cited works
Essential medicines for universal health coverage
Veronika J. Wirtz, Hans V. Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis P de Joncheere, Margaret Ewen, Martha Gyansa‐Lutterodt, Sun Jing, Vera Lúcia Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross‐Degnan, Peter Stephens, Yot Teerawattananon, Ellen ‘t Hoen, Anita K. Wagner, Prashant Yadav, Michael R. Reich
The Lancet. 2016634 CitationsOPEN ACCESS
Short and long term impacts of COVID-19 on the pharmaceutical sector
Nayyereh Ayati, Parisa Saiyarsarai, Shekoufeh Nikfar
S47297815. 2020258 CitationsOPEN ACCESS
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Marjan Walli-Attaei, Rasha Khatib, Martin McKee, Scott A. Lear, Gilles R. Dagenais, Ehimario Igumbor, Khalid F. AlHabib, Manmeet Kaur, Iolanthé M. Kruger, Koon Teo, Fernando Laņas, Khalid Yusoff, Aytekin Oğuz, Rajeev Gupta, Afzalhussein Yusufali, Ahmad Bahonar, Raman Kutty, Annika Rosengren, Viswanathan Mohan, Álvaro Avezum, Rita Yusuf, Andrzej Szuba, Sumathy Rangarajan, Clara K Chow, Salim Yusuf, Salim Yusuf, Sumathy Rangarajan, Koon Teo, Clara K Chow, Martin O’Donnell, Andrew Mente, Darryl P. Leong, Andrew Smyth, Philip Joseph, Shofiqul Islam, M Zhang, Weiwei Hu, Chinthanie Ramasundarahettige, Gary Wong, Lovely Dayal, Amparo Casanova, Mahshid Dehghan, Gregory D. Lewis, Antonio Aliberti, Álvaro Reyes, Ahmed Zaki, Basil S. Lewis, B Zhang, D Agapay, Danielle M. Hari, E Milazzo, E Ramezani, F Hussain, Fathimath Shifaly, I Kay, Julija Rimac, John G. Swallow, L Heldman, Maha Mushtaha, Maha Mushtaha, Mark Trottier, N Aoucheva, N Kandy, Pam Mackie, R Solano, Siu Lim Chin, S Ramacham, Sadequa Shahrook, S Trottier, T Tongana, W Elsheikh, J Lindeman, Matt J. McQueen, Kellie Hall, J. Keys, Xuechao Wang, J Keneth, Anitha Devanath, Rafael Díaz, Andrés Orlandini, B Linetsky, S Toscanelli, Germana Casaccia, JM Maini Cuneo, Omar Rahman, Rita Yusuf, AK Azad, Khondkar Ayaz Rabbani, HM Cherry, Adnan Mannan, I Hassan, AT Talukdar, RB Tooheen, MU Khan, Mariz Sintaha, Tarzia Choudhury, Md Rabiul Haque, S Parvin, Álvaro Avezum, GB Oliveira
S2764808104. 2017218 CitationsOPEN ACCESS
The selection and use of essential medicines.
Peter N. Kazembe, Jehan Al Fannah, Kalle Hoppu, Elizabeta Zisovska, HB Pedersen, S Hill, Clive Ondari, Dianne J. Terlouw, Donald R. Mattison, LI Zhi-ping, Dinesh Kumar Mehta, Anwarul Hassan Gilani, P Chongtrakul, Gregory L. Kearns, Jamie Robertson, Alar Irs, E. Huw Davies, Noel Cranswick, S Walters, Helena Coelho, A Helali, HV Hogerzeil, Hisae Nakamura, Andy Gray, M M Reidenberg, Sri Suryawati, Uttam GUPTA
PubMed. 2004216 Citations
Introduction to drug utilization research
Björn Wettermark, Monique Elseviers, Tanja Mueller, Anna Birna Almarsdóttir, Ria Benkő, Marion Bennie, Irina Iaru, Katarina Gvozdanović, Mikael Hoffmann, Verica Ivanovska, Seán MacBride‐Stewart, Elisabetta Poluzzi, Lisa Pont, Hege Salvesen Blix, Gabriel Sanfélix‐Gimeno, Gisbert Selke, Katja Taxis, Ana Tomas Petrović, Indrė Trečiokienė, Sabine Vogler
2024211 CitationsOPEN ACCESS
Where is Pharmaceutical Economics and Policy research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Pharmaceutical Economics and Policy is open access?
ScholarIQopen access share
60%OPEN ACCESS
Gold
27%
Green
7%
Hybrid
7%
Bronze
20%
Closed
40%
Related on ScholarIQ
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paper
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paper
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Paper
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Paper
Data Resource Profile: The Danish National Prescription Registry
Paper
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
Paper